Taiwan's National Health Insurance (NHI) system has approved its first-ever patient to receive a one-time NT$49 million (US$1.53 million) drug for spinal muscular atrophy (SMA), which was added to a list of covered treatments earlier this month, an official said Monday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
'Zombie drug' set to be reclassified as Category 2 narcotic: Premier
11/13/2024 07:19 PM - Politics
Taiwan to devise new means of cooperation with U.S.: Premier
11/13/2024 06:49 PM - Politics
Minister questioned over possible seating of Chinese spouse in Legislature
11/13/2024 06:24 PM - Society
Nantou elementary school teacher jailed 13 years for sexual offenses
11/13/2024 04:58 PM - Society
Overseas visitor arrivals surpass 2023 numbers: Tourism Administration
11/13/2024 04:39 PM